ACT 1
A trial reviewing Carotid Angioplasty and stenting versus endarterectomy in asymptomatic subjects, who are at standard risk for carotid endarterectomy with significant extracranial carotid occlusive disease.
Research Coordinator: Jill Stone 336-718-5810
CAPTURE 2
A registry to collect data of safety and efficacy using the RX ACCULINK and RX ACCUNET Systems to uncover unanticipated or rare events.
Research Coordinator: Debra Wilson 336-718-5810
CREST
The purpose of the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) is to compare the relatively new procedure of stent-assisted carotid angioplasty (CAS) to the traditional and accepted surgical approach of carotid endarterectomy (CEA) for the treatment of carotid artery stenosis to prevent recurrent strokes in those patients who have had a TIA (transient ischemic attack) or a mild stroke within the past six months (symptomatic) and in those patients who have not had any symptoms within the past six months (asymptomatic).
Research Coordinator: Tammy Snow 336-718-5810
NUVELO
The purpose of this study is to directly compare the safety and efficacy of intra-thrombus alfimeprase 0.3 mg/kg (study drug) with placebo in acute peripheral arterial occlusion (PAO) as measured by a 30 day open vascular free surgery rate.
Research Coordinator: Sherry Duncan 336-718-5810
PENUMBRA
The purpose of this clinical evaluation is to assess the safety and effectiveness of the Penumbra System (study device) in the revascularization of patients presenting with acute ischemic stroke secondary to intracranial, large vessel, occlusive disease.
Research Coordinator: Jill Stone 336-718-5810
PROGUARD
The purpose of this study is to evaluate the safety and efficacy of the TriActiv® ProGuard System when used during a stent placement in a blockage within the carotid artery in patients considered to be at high risk for complications from surgical endarterectomy.
Research Coordinator: Tammy Snow 336-718-5810
